Long-term survival patients with acute and severe renal failure due to multiple myeloma

S. Pasquali, S. Casanova, A. Zucchelli, P. Zucchelli

Research output: Contribution to journalArticle

Abstract

We selected 37 cases, followed-up for more than 36 months or until death, from a series of 45 patients affected by acute renal failure due to multiple myeloma in order to identify the parameters that could allow the outcome to be predicted. The patients were allocated to group 1, consisting of 27 patients who died within one year and to group 2, consisting of 10 patients who survived for more than 36 months. Renal failure was severe enough to require dialysis in 28 patients, 16 of whom were oliguric. Renal biopsy was performed in 23 cases, whereas light chain isoelectric point and serum β 2-microglobulin levels were evaluated in each patient. All the patients underwent chemotherapy, which was associated with plasma exchange in 16 patients. Statistical analysis of the potential prognostic factors in the 2 groups showed that the incidence of hypercalcemia, infection, irreversible renal failure and severe tubulo-interstitial damage was significantly higher in group 1. Sex, tumor load, severity of renal failure and light chain isoelectric point had no prognostic significance. Finally, the number of patients treated by plasma exchange was significantly higher in group 2. Our results underline the prognostic role of both hypercalcemia and infection and justify aggressive treatment consisting of chemotherapy, plasma exchange and dialysis, even in cases of severe renal failure and high tumor load.

Original languageEnglish
Pages (from-to)247-254
Number of pages8
JournalClinical Nephrology
Volume34
Issue number6
Publication statusPublished - 1990

Fingerprint

Multiple Myeloma
Acute Kidney Injury
Survival
Plasma Exchange
Renal Insufficiency
Isoelectric Point
Hypercalcemia
Tumor Burden
Dialysis
Light
Drug Therapy
Infection
Kidney
Biopsy
Incidence
Serum

Keywords

  • multiple myeloma
  • renal failure
  • survival rate

ASJC Scopus subject areas

  • Nephrology

Cite this

Pasquali, S., Casanova, S., Zucchelli, A., & Zucchelli, P. (1990). Long-term survival patients with acute and severe renal failure due to multiple myeloma. Clinical Nephrology, 34(6), 247-254.

Long-term survival patients with acute and severe renal failure due to multiple myeloma. / Pasquali, S.; Casanova, S.; Zucchelli, A.; Zucchelli, P.

In: Clinical Nephrology, Vol. 34, No. 6, 1990, p. 247-254.

Research output: Contribution to journalArticle

Pasquali, S, Casanova, S, Zucchelli, A & Zucchelli, P 1990, 'Long-term survival patients with acute and severe renal failure due to multiple myeloma', Clinical Nephrology, vol. 34, no. 6, pp. 247-254.
Pasquali S, Casanova S, Zucchelli A, Zucchelli P. Long-term survival patients with acute and severe renal failure due to multiple myeloma. Clinical Nephrology. 1990;34(6):247-254.
Pasquali, S. ; Casanova, S. ; Zucchelli, A. ; Zucchelli, P. / Long-term survival patients with acute and severe renal failure due to multiple myeloma. In: Clinical Nephrology. 1990 ; Vol. 34, No. 6. pp. 247-254.
@article{640960b57c2b497b864d14ffc7fad269,
title = "Long-term survival patients with acute and severe renal failure due to multiple myeloma",
abstract = "We selected 37 cases, followed-up for more than 36 months or until death, from a series of 45 patients affected by acute renal failure due to multiple myeloma in order to identify the parameters that could allow the outcome to be predicted. The patients were allocated to group 1, consisting of 27 patients who died within one year and to group 2, consisting of 10 patients who survived for more than 36 months. Renal failure was severe enough to require dialysis in 28 patients, 16 of whom were oliguric. Renal biopsy was performed in 23 cases, whereas light chain isoelectric point and serum β 2-microglobulin levels were evaluated in each patient. All the patients underwent chemotherapy, which was associated with plasma exchange in 16 patients. Statistical analysis of the potential prognostic factors in the 2 groups showed that the incidence of hypercalcemia, infection, irreversible renal failure and severe tubulo-interstitial damage was significantly higher in group 1. Sex, tumor load, severity of renal failure and light chain isoelectric point had no prognostic significance. Finally, the number of patients treated by plasma exchange was significantly higher in group 2. Our results underline the prognostic role of both hypercalcemia and infection and justify aggressive treatment consisting of chemotherapy, plasma exchange and dialysis, even in cases of severe renal failure and high tumor load.",
keywords = "multiple myeloma, renal failure, survival rate",
author = "S. Pasquali and S. Casanova and A. Zucchelli and P. Zucchelli",
year = "1990",
language = "English",
volume = "34",
pages = "247--254",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "6",

}

TY - JOUR

T1 - Long-term survival patients with acute and severe renal failure due to multiple myeloma

AU - Pasquali, S.

AU - Casanova, S.

AU - Zucchelli, A.

AU - Zucchelli, P.

PY - 1990

Y1 - 1990

N2 - We selected 37 cases, followed-up for more than 36 months or until death, from a series of 45 patients affected by acute renal failure due to multiple myeloma in order to identify the parameters that could allow the outcome to be predicted. The patients were allocated to group 1, consisting of 27 patients who died within one year and to group 2, consisting of 10 patients who survived for more than 36 months. Renal failure was severe enough to require dialysis in 28 patients, 16 of whom were oliguric. Renal biopsy was performed in 23 cases, whereas light chain isoelectric point and serum β 2-microglobulin levels were evaluated in each patient. All the patients underwent chemotherapy, which was associated with plasma exchange in 16 patients. Statistical analysis of the potential prognostic factors in the 2 groups showed that the incidence of hypercalcemia, infection, irreversible renal failure and severe tubulo-interstitial damage was significantly higher in group 1. Sex, tumor load, severity of renal failure and light chain isoelectric point had no prognostic significance. Finally, the number of patients treated by plasma exchange was significantly higher in group 2. Our results underline the prognostic role of both hypercalcemia and infection and justify aggressive treatment consisting of chemotherapy, plasma exchange and dialysis, even in cases of severe renal failure and high tumor load.

AB - We selected 37 cases, followed-up for more than 36 months or until death, from a series of 45 patients affected by acute renal failure due to multiple myeloma in order to identify the parameters that could allow the outcome to be predicted. The patients were allocated to group 1, consisting of 27 patients who died within one year and to group 2, consisting of 10 patients who survived for more than 36 months. Renal failure was severe enough to require dialysis in 28 patients, 16 of whom were oliguric. Renal biopsy was performed in 23 cases, whereas light chain isoelectric point and serum β 2-microglobulin levels were evaluated in each patient. All the patients underwent chemotherapy, which was associated with plasma exchange in 16 patients. Statistical analysis of the potential prognostic factors in the 2 groups showed that the incidence of hypercalcemia, infection, irreversible renal failure and severe tubulo-interstitial damage was significantly higher in group 1. Sex, tumor load, severity of renal failure and light chain isoelectric point had no prognostic significance. Finally, the number of patients treated by plasma exchange was significantly higher in group 2. Our results underline the prognostic role of both hypercalcemia and infection and justify aggressive treatment consisting of chemotherapy, plasma exchange and dialysis, even in cases of severe renal failure and high tumor load.

KW - multiple myeloma

KW - renal failure

KW - survival rate

UR - http://www.scopus.com/inward/record.url?scp=0025678621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025678621&partnerID=8YFLogxK

M3 - Article

C2 - 2073767

AN - SCOPUS:0025678621

VL - 34

SP - 247

EP - 254

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 6

ER -